SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950124-02-000883
Filing Date
2002-03-19
Accepted
2002-03-19 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO ANNUAL REPORT k67962a1e10-ka.htm 10-K/A 690788
3 EX-10.37 MEMORANDUM OF UNDERSTANDING k67962a1ex10-37.txt EX-10.37 10621
4 EX-10.38 LOAN AND SECURITY AGREEMENT k67962a1ex10-38.txt EX-10.38 56178
5 EX-10.39 LOAN MODIFICATION AGREEMENT k67962a1ex10-39.txt EX-10.39 4603
6 EX-10.40 CONFIRMATION OF SUBLEASE TERMS k67962a1ex10-40.txt EX-10.40 1587
7 EX-21.1 SUBSIDIARIES OF ESPERION THERAPEUTICS INC. k67962a1ex21-1.txt EX-21.1 766
8 EX-23.1 CONSENT OF ARTHUR ANDERSEN LLP k67962a1ex23-1.txt EX-23.1 682
  Complete submission text file 0000950124-02-000883.txt   767607
Mailing Address 3621 STATE STREET 695 KMS PLACE ANN ARBOR MI 48108
Business Address 3621 S STATE STREET 695KMS PLACE 734-332-0506 ANN ARBOR MI 48108
ESPERION THERAPEUTICS INC/MI (Filer) CIK: 0001066745 (see all company filings)

IRS No.: 383419139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16033 | Film No.: 02578693
SIC: 2834 Pharmaceutical Preparations